US Patent Issued to Quicksilver Scientific on June 16 for "Intra-oral nanoemulsion including monolayer surfactant bound particles for balancing histamine response" (Colorado Inventors)

ALEXANDRIA, Va., June 16 -- United States Patent no. 12,653,854, issued on June 16, was assigned to Quicksilver Scientific Inc. (Louisville, Colo.).

"Intra-oral nanoemulsion including monolayer surfactant bound particles for balancing histamine response" was invented by Christopher W. Shade (Louisville, Colo.) and Steven Tieu (Louisville, Colo.).

According to the abstract* released by the U.S. Patent & Trademark Office: "An intra-oral, nanoemulsion assists in balancing the histamine response in subjects when orally administered. The intra-oral, nanoemulsion includes at least one monolayer surfactant bound particle and a continuous phase. The monolayer surfactant bound particles are carried by the continuous phase. A method of making and o...